A groundbreaking treatment, jointly oxidants developed by the University of South Australia and the University of Sheffield, revolutionizes wound management through the plasma activation of hydrogel dressings. This innovative approach generates a unique blend of chemical oxidants within the dressings, effectively decontaminating wounds and facilitating the healing process upon application.
Oxidants
Clinical trials have already validated the efficacy of cold plasma ionized gas in controlling infections and promoting healing, as confirmed by the Sheffield announcement. This remarkable outcome stems from the potent chemical composition of oxidants, particularly the reactive oxygen and nitrogen species (RONS) generated when oxygen and nitrogen molecules in the air are activated and mixed.
The newfound method represents a significant leap forward in combatting antibiotic-resistant pathogens and holds immense promise in transforming the treatment landscape for diabetic foot ulcers and internal wounds. Professor Rob Short of Sheffield, a co-author of the study, underscores the urgency of addressing the global diabetes pandemic, with over 540 million individuals affected worldwide, 30% of whom are predisposed to foot ulcers.
Alarmingly, oxidants between 60,000 and 75,000 people in England alone receive treatment for diabetic foot ulcers weekly, with infection posing a substantial risk. The rise of antibiotic-resistant bacteria exacerbates the situation, leading to approximately 7,000 amputations annually and underscoring the imperative for innovative wound management solutions.
Dr. Endre Szili from the University of South Australia, who spearheaded the research, highlights the limitations of conventional approaches such as antibiotics and silver dressings. Antibiotic resistance poses a formidable global challenge, while concerns regarding silver-induced toxicity prompt the phasing out of silver dressings in Europe. In response, the team’s pioneering work demonstrates that plasma-activating hydrogel dressings enriched with RONS exhibit enhanced efficacy in combating common bacteria such as E. coli and P. aeruginosa.
Beyond its antimicrobial properties, plasma-activated hydrogels show promise in stimulating the body’s immune response, further bolstering the fight against infections. While the study primarily focuses on diabetic foot ulcers, the researchers assert the versatility of the technology, suggesting its potential application in managing all chronic wounds and internal infections.
The emergence of this groundbreaking treatment marks a watershed moment in wound care, offering renewed hope for millions grappling with chronic wounds and antibiotic resistance. As research advances, the integration of plasma-activated hydrogel dressings promises to redefine the standard of care, heralding a new era in therapeutic interventions for wound healing and infection control.
-
-
-
-
